Your browser doesn't support javascript.
Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Djomkam, Alexandra Lindsey Zune; Olwal, Charles Ochieng'; Sala, Theodore Beyeme; Paemka, Lily.
  • Djomkam ALZ; West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra, Ghana.
  • Olwal CO; Department of Biochemistry, Cell and Molecular Biology, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.
  • Sala TB; West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra, Ghana.
  • Paemka L; Department of Biochemistry, Cell and Molecular Biology, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.
Front Oncol ; 10: 1448, 2020.
Article in English | MEDLINE | ID: covidwho-1389220
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Front Oncol Year: 2020 Document Type: Article Affiliation country: FONC.2020.01448

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Front Oncol Year: 2020 Document Type: Article Affiliation country: FONC.2020.01448